ITM Power PLC (LON:ITM) has announced the opening of its 4th hydrogen refuelling station (‘HRS’) in the UK, and the first partnering with petrochemical giant Shell. This following the announcement
City of London Investment Group Plc (LON:CLIG) is the topic of discussion when Robin Savage, Research Director at Zeus Capital caught up with DirectorsTalk. Robin compares the interim results for
Zeus Capital’s Dr Gary Waanders discusses Allergy Therapeutics plc in this exclusive interview with DirectorsTalk
Xafinity plc (LON:XAF) is a UK specialist in pensions actuarial, consulting and administration business providing a wide range of advisory and compliance services to over 550 pension scheme clients which
Allergy Therapeutics Plc (LON:AGY) is the topic of conversation with Dr Gary Waanders Director of Healthcare Research at Zeus Capital. Since Allergy Therapeutics announced today that it has obtained approval
Zeus Capital’s Dr Gary Waanders dsicusses Oncimmune Holdings PLC in this exclusive interview with DirectorsTalk
Allergy Therapeutics plc (LON:AGY) is a UK-based, specialty pharmaceutical company focused on the development, manufacture and sale of vaccines and other products for the treatment and prevention of allergies. This
Oncimmune Holdings Plc (LON:ONC) is the topic of conversation when Dr Gary Waanders the Director of Healthcare Research at Zeus Capital caught up with DirectorsTalk. Gary talks us through the
Oncimmune Holdings plc (LON:ONC), a pioneering UK-based biotech developing and commercialising blood tests for early cancer detection, today released its Interim results for the 6 months to November 30, 2016
Entu (UK) plc (LON:ENTU) has announced that EBITDA from continuing operations will be within the range of its previous guidance of £2.5m to £2.9m at £2.6m to £2.7m. This is
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
